|1.||McGuffin, Peter: 13 articles (12/2014 - 01/2009)|
|2.||Uher, Rudolf: 13 articles (12/2014 - 01/2009)|
|3.||Mors, Ole: 11 articles (12/2014 - 01/2009)|
|4.||Maier, Wolfgang: 11 articles (12/2014 - 01/2009)|
|5.||Henigsberg, Neven: 11 articles (12/2014 - 01/2009)|
|6.||Hauser, Joanna: 9 articles (12/2014 - 01/2009)|
|7.||Aitchison, Katherine J: 9 articles (02/2013 - 01/2009)|
|8.||Placentino, Anna: 9 articles (12/2012 - 01/2009)|
|9.||Souery, Daniel: 8 articles (12/2014 - 01/2009)|
|10.||Farmer, Anne: 8 articles (12/2014 - 03/2009)|
06/01/1998 - "Reduction in pain intensity scores was significantly greater for participants randomized to nortriptyline (difference in mean change 1.68, 95%-0.001, CI -3.36, P = 0.050), with a reduction of pain by 22% compared to 9% on placebo. "
05/01/2010 - "Although nortriptyline was effective for her pain, it could bring about fatal cardiac adverse events. "
12/01/2011 - "One patient had further cryoanalgesia, one was referred for specialist pain management, and one controlled the pain with nortriptyline. "
05/01/2009 - "Correspondingly in the 30 people treated with nortriptyline, the mean (SD) intensity of pain and/or sensory complaints decreased from 4.9 (1.9) to 3.3 (2.1) (P < 0.001). "
11/01/1999 - "Nortriptyline had no effect on the pain scores. "
02/11/1984 - "Post-stroke depressions are common, severe, and longstanding, and the demonstrated efficacy of nortriptyline provides an important addition to the treatments available for stroke patients."
02/11/1984 - "The efficacy of nortriptyline in the treatment of post-stroke depression was assessed by a double-blind study in thirty-four patients. "
05/01/2003 - "There were no significant differences between the nortriptyline and placebo groups in demographic characteristics, stroke type, and neurological findings. "
04/07/1984 - "Nortriptyline for post-stroke depression."
03/03/1984 - "Side-effects of nortriptyline treatment for post-stroke depression."
|3.||Major Depressive Disorder (Major Depressive Disorders)
04/01/2014 - "In the present study, we used PET and (S,S)-[18¹⁸F]FMeNER-D₂ to investigate NET occupancies in the thalamus in 10 patients with major depressive disorder taking various doses of nortriptyline, who were considered to be responders to the treatment. "
07/01/1992 - "Data are presented on the baseline characteristics and 2- to 3-year follow-up assessments of placebo-washout responders (PWRs) from a previously reported pharmacokinetically designed double-blind placebo-controlled trial of nortriptyline for major depressive disorder in 6- to 12-year-olds. "
01/01/1992 - "A random assignment, double-blind, placebo-controlled study of nortriptyline in 50 prepubertal 6- to 12-year-olds with Research Diagnostic Criteria and DSM-III major depressive disorder was performed. "
01/01/1992 - "Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder."
01/01/1990 - "We performed a random assignment, double-blind, placebo-controlled study of nortriptyline (NT) in postpubertal 12- to 17-year-olds with Research Diagnostic Criteria (RDC) and DSM-III major depressive disorder. "
|4.||Neuralgia (Stump Neuralgia)
01/01/2015 - "We found little evidence to support the use of nortriptyline to treat the neuropathic pain conditions included in this review. "
01/01/2015 - "We included randomised, double-blind studies of at least two weeks' duration comparing nortriptyline with placebo or another active treatment in chronic neuropathic pain. "
01/01/2015 - "To assess the analgesic efficacy and associated adverse events of nortriptyline for chronic neuropathic pain in adults. "
01/01/2015 - "Nortriptyline for neuropathic pain in adults."
08/01/2010 - "MORs are thus not critical for nortriptyline action against neuropathic pain. "
01/01/1992 - "Preliminary analysis of global outcome on the first 52 patients reveals that those receiving nortriptyline were more likely to feel that their drug had been helpful (74% vs. 36%, p less than 0.01), but were equally likely to report that their tinnitus was improved (37% vs. 32%, NS). "
11/01/1989 - "To explore further this link between tinnitus and depression, and to investigate the efficacy of treating depression in the treatment of tinnitus, a single-blind, placebo-washout, nonrandomized pilot study of the tricyclic antidepressant nortriptyline (hydrochloride) was undertaken in disabled tinnitus patients who also met diagnostic criteria for major depression. "
10/11/1993 - "To determine whether the antidepressant, nortriptyline, is effective for treatment of depression, tinnitus-related disability, and tinnitus symptoms in patients with severe chronic tinnitus. "
11/01/1989 - "Fourteen considered their tinnitus improved, and 12 chose to continue taking nortriptyline after the study. "
10/11/1993 - "A randomized trial of nortriptyline for severe chronic tinnitus. "
|6.||Tricyclic Antidepressive Agents (Tricyclic Antidepressants)
|9.||Antidepressive Agents (Antidepressants)
|10.||Morphine (MS Contin)
|1.||Vasectomy (Vas Occlusion)
|2.||Transcutaneous Electric Nerve Stimulation (TENS)
|5.||Drug Therapy (Chemotherapy)